SUNNYVALE, Calif. , July 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd (CNNC Accuray). CNNC Accuray has received the Radiation Safety License from the
SUNNYVALE, Calif. , July 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife ® and Radixact ® System software innovations were shared by prominent physicists at the recent 61 st annual meeting of the American Association
SUNNYVALE, Calif. , Aug. 15, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019 . Q4 Fiscal 2019 and Recent Operating Highlights Revenue increased 3 percent to $117.4 million , the highest ever
Advanced Radiation Therapy Delivery System and Intrafraction Motion Synchronization Functionality Enable Precise, Efficient Treatment of a 45-Year-Old Man with Lung Cancer SUNNYVALE, Calif. , Aug. 21, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that physicians at the
Presentations will be Live Webcast and Commence at 3:00pm CT SUNNYVALE, Calif. , Sept. 4, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held
SUNNYVALE, Calif. , Sept. 5, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it will showcase its industry-leading motion-synchronization cancer treatment technologies at the upcoming American Society for Radiation Oncology (ASTRO) Annual Meeting taking place
Leading Health Services Organization Hospital Selected the New Radiation Therapy Device to Expand Its Clinical Capabilities and Provide Treatment Options for a Wider Range of Patients SUNNYVALE, Calif. , Sept. 10, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the
SUNNYVALE, Calif. , Sept. 12, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) strengthened its Board of Directors with the appointment of James (Jim) M. Hindman , effective as of September 6, 2019 , and expanding the company's Board to nine members. Mr.
SUNNYVALE, Calif. , Sept. 16, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, on September 11, 2019 , China's Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators. The tariff exemption, which will be effective September
SUNNYVALE, Calif. , Sept. 17, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announces that The Lancet Oncology , a high impact and leading global peer-reviewed oncology journal, has published patient- and clinician-reported outcomes data from the PACE — Prostate Advances in Comparative
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
